Back to search
FDAFDA · Food and drugs·Recall number D-0186-2021

Atropine Sulfate Injection, 0.8 mg/2 mL (0.4 mg/mL), 2 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004004006

Published January 13, 2021 · Recall initiated: December 17, 2020

Summary

FDA records drug Class II recall D-0186-2021, published January 13, 2021 and initiated December 17, 2020. Recalling firm: SCA Pharmaceuticals; Status: Terminated; Reported quantity: 1,930 syringes; Lot: Lot # 1220023001, BUD 2/5/2021; 1220023126, BUD 2/9/2021 & 1220023606, BUD 2/25/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SCA Pharmaceuticals
Distributor
Product was distributed to hospitals nationwide.
Lot
Lot # 1220023001, BUD 2/5/2021; 1220023126, BUD 2/9/2021 & 1220023606, BUD 2/25/2021.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atropine Sulfate Injection, 0.8 mg/2 mL (0.4 mg/mL), 2 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004004006 recalled?

Yes. FDA published recall D-0186-2021 on January 13, 2021. Reported hazard: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

What should I do if I have this product?

Voluntary: Firm initiated · Letter